SEC Tracker
Get the app

LifeStance Health Group LFST

LifeStance Health Group Q1 FY26: revenue $403.5M, up 21%

Form
10-Q
Filed
Period
Importance
Notable

Key figures from this report

These are the numbers LifeStance Health Group reported for Q1 FY26, the quarter ended Mar 31, 2026, as tagged in the filing’s XBRL data, each against the same quarter a year earlier. A plain-English reading of this report is not written yet.

  1. Revenue$403.5M+21% from $333.0M in Q1 FY2510-Q income statement, on EDGAR
  2. Net income$14.2M+1909% from $709K in Q1 FY2510-Q income statement, on EDGAR
  3. Cash and cash equivalents$194.8M+45% from $134.3M in Q1 FY2510-Q balance sheet, on EDGAR
  4. Cash from operations$33.1MAgainst −$3.1M in Q1 FY2510-Q cash flow statement, on EDGAR

Every quarter in the financial tables

View on EDGAR

Open in the app

Get an email when LifeStance Health Group files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 8000 and related industry codes: the same peer list as the financial tables.

  1. U S Physical Therapy USPH public float $737M, Jun 30, 2025
  2. Pennant Group PNTG public float $989M, Jun 30, 2025
  3. Omada Health OMDA public float $1.1B, Jun 30, 2025
  4. GeneDx Holdings WGS public float $1.7B, Jun 30, 2025
  5. Talkspace TALK public float $393M, Jun 30, 2025